SG34210A1 - Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract - Google Patents
Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tractInfo
- Publication number
- SG34210A1 SG34210A1 SG1995000074A SG1995000074A SG34210A1 SG 34210 A1 SG34210 A1 SG 34210A1 SG 1995000074 A SG1995000074 A SG 1995000074A SG 1995000074 A SG1995000074 A SG 1995000074A SG 34210 A1 SG34210 A1 SG 34210A1
- Authority
- SG
- Singapore
- Prior art keywords
- active ingredient
- medicinal active
- targeted site
- pharmaceutical preparation
- intestinal tract
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6040911A JP2917799B2 (ja) | 1994-03-11 | 1994-03-11 | 消化管内適所放出型製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG34210A1 true SG34210A1 (en) | 1996-12-06 |
Family
ID=12593695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG1995000074A SG34210A1 (en) | 1994-03-11 | 1995-03-08 | Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract |
Country Status (14)
Country | Link |
---|---|
US (1) | US5725880A (de) |
EP (1) | EP0671168B1 (de) |
JP (1) | JP2917799B2 (de) |
KR (1) | KR100305234B1 (de) |
CN (1) | CN1116523A (de) |
AT (1) | ATE193439T1 (de) |
CA (1) | CA2144094C (de) |
DE (1) | DE69517218T2 (de) |
DK (1) | DK0671168T3 (de) |
ES (1) | ES2148365T3 (de) |
GR (1) | GR3033593T3 (de) |
PT (1) | PT671168E (de) |
SG (1) | SG34210A1 (de) |
TW (1) | TW422708B (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2120354B1 (es) * | 1996-02-12 | 1999-07-01 | Univ Sevilla | Dispositivo terapeutico para direccionar farmacos hacia el tramo del tracto gastrointestinal deseado en funcion de las caracteristicas fisicoquimicas del mismo. |
DE19732903A1 (de) | 1997-07-30 | 1999-02-04 | Falk Pharma Gmbh | Pellet-Formulierung zur Behandlung des Intestinaltraktes |
IN186245B (de) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
KR100501022B1 (ko) | 1998-07-28 | 2005-07-18 | 다나베 세이야꾸 가부시키가이샤 | 장내 적소 방출형 제제 |
CA2360655C (en) | 1999-01-29 | 2007-03-20 | Losan Pharma Gmbh | Pharmaceutical compositions |
FR2790387B1 (fr) * | 1999-03-01 | 2001-05-18 | Prographarm Laboratoires | Comprime orodispersible presentant une faible friabilite et son procede de preparation |
US6270807B1 (en) | 1999-03-02 | 2001-08-07 | L. Perrigo Company | Taste-masked pharmaceutical composition |
US6245913B1 (en) | 1999-06-30 | 2001-06-12 | Wockhardt Europe Limited | Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole |
WO2001054671A1 (fr) * | 2000-01-27 | 2001-08-02 | Tanabe Seiyaku Co., Ltd. | Preparation a liberation prolongee et son procede de fabrication |
US6420473B1 (en) | 2000-02-10 | 2002-07-16 | Bpsi Holdings, Inc. | Acrylic enteric coating compositions |
WO2001058429A1 (en) * | 2000-02-10 | 2001-08-16 | Bpsi Holdings, Inc. | Acrylic enteric coating compositions |
IT1318625B1 (it) * | 2000-07-14 | 2003-08-27 | Roberto Valducci | Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente. |
US20030072731A1 (en) * | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing starch or dextrin |
AU4061702A (en) * | 2001-05-15 | 2003-04-03 | Mcneil-Ppc, Inc. | Dip coating compositions containing starch or dextrin |
US20030070584A1 (en) * | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
US8309118B2 (en) * | 2001-09-28 | 2012-11-13 | Mcneil-Ppc, Inc. | Film forming compositions containing sucralose |
US7429619B2 (en) * | 2002-08-02 | 2008-09-30 | Mcneil Consumer Healthcare | Polyacrylic film forming compositions |
US20040185093A1 (en) * | 2003-03-18 | 2004-09-23 | Szymczak Christopher E. | Compositions containing sucralose |
WO2004087109A1 (ja) * | 2003-03-27 | 2004-10-14 | Hisamitsu Pharmaceutical Co., Inc. | 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤 |
US8916546B2 (en) | 2003-08-29 | 2014-12-23 | Therapeutic Research Llc | Materials and methods for treatment and diagnosis of disorders associated with oxidative stress |
GB0320522D0 (en) * | 2003-09-02 | 2003-10-01 | Glaxo Group Ltd | Formulation |
GB0400452D0 (en) * | 2004-01-09 | 2004-02-11 | Norton Healthcare Ltd | A pharmaceutical composition |
US20060024368A1 (en) * | 2004-07-30 | 2006-02-02 | Reza Fassihi | Compressed composite delivery system for release-rate modulation of bioactives |
US20060062811A1 (en) * | 2004-09-21 | 2006-03-23 | Szymczak Christopher E | Medicinal cooling emulsions |
JPWO2007010846A1 (ja) * | 2005-07-15 | 2009-01-29 | キッセイ薬品工業株式会社 | 胃内滞留製剤 |
AU2006274835B2 (en) | 2005-07-29 | 2012-05-24 | Abbott Laboratories Gmbh | Processes for the manufacture of sterilized pancreatin powder |
US9198871B2 (en) * | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
US11266607B2 (en) * | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
ATE457719T2 (de) | 2005-08-15 | 2010-03-15 | Solvay Pharm Gmbh | Pharmazeutische zusammensetzungen mit kontrollierter freisetzung für säurelabile arzneimittel |
US10072256B2 (en) * | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
EP2105133A1 (de) * | 2007-01-15 | 2009-09-30 | Kissei Pharmaceutical Co., Ltd. | Herstellung schwebender intragastraler levodopa mit verzögerter freisetzung |
WO2008132727A2 (en) * | 2007-04-26 | 2008-11-06 | Technion Research And Development Foundation Ltd | Oral delivery of proteins and peptides |
CN101707877B (zh) | 2007-06-13 | 2013-01-09 | 杰伊·普拉夫达 | 诊断与治疗氧化过激类病症的材料和方法 |
US20090036414A1 (en) * | 2007-08-02 | 2009-02-05 | Mutual Pharmaceutical Company, Inc. | Mesalamine Formulations |
US20090130063A1 (en) * | 2007-11-15 | 2009-05-21 | Solvay Pharmaceuticals Gmbh | Process for separating and determining the viral load in a pancreatin sample |
MX2011003595A (es) | 2008-10-03 | 2011-07-28 | Falk Pharma Gmbh | Composiciones y metodos para el tratamiento de enfermedades intestinales con mesalamina granulada. |
EP2255794A1 (de) * | 2009-05-29 | 2010-12-01 | H e x a l Aktiengesellschaft | Magensaftresistenter Überzug |
JP5496616B2 (ja) * | 2009-11-18 | 2014-05-21 | フロイント産業株式会社 | 大腸ドラッグデリバリーシステム製剤 |
US10463699B2 (en) | 2016-04-04 | 2019-11-05 | Omeza LLC | Fish oil topical composition |
US10765635B2 (en) * | 2018-02-06 | 2020-09-08 | Nano Pharmaceutical Laboratories Llc | Multiparticulate including pharmaceutical or probiotic active ingredients for delivery via a shelf stable liquid dosage form |
AU2022307756A1 (en) * | 2021-07-09 | 2024-02-22 | Evonik Operations Gmbh | Composition comprising a (meth)acrylate copolymer, an alkali or ammonium salt of a saturated aliphatic monocarboxylic acid and specific glidants |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3325365A (en) * | 1963-04-02 | 1967-06-13 | Ciba Geigy Corp | Enteric composition for tablet compression coating |
US3608030A (en) * | 1969-05-21 | 1971-09-21 | Howard Tint | Method of preparing a tablet dosage-form for the immunization of the intestinal tract with live virus preparations |
GB1456365A (en) * | 1972-10-06 | 1976-11-24 | Gist Brocades Nv | Controlled release composition |
CA1308357C (en) * | 1987-01-28 | 1992-10-06 | Tohru Chiba | Method for the preparation of a coated solid medicament |
JP2773959B2 (ja) * | 1990-07-10 | 1998-07-09 | 信越化学工業株式会社 | 大腸内放出性固形製剤 |
US5162117A (en) * | 1991-11-22 | 1992-11-10 | Schering Corporation | Controlled release flutamide composition |
-
1994
- 1994-03-11 JP JP6040911A patent/JP2917799B2/ja not_active Expired - Fee Related
-
1995
- 1995-03-07 CA CA002144094A patent/CA2144094C/en not_active Expired - Fee Related
- 1995-03-08 SG SG1995000074A patent/SG34210A1/en unknown
- 1995-03-10 TW TW084102273A patent/TW422708B/zh not_active IP Right Cessation
- 1995-03-10 US US08/402,052 patent/US5725880A/en not_active Expired - Fee Related
- 1995-03-10 DK DK95103493T patent/DK0671168T3/da active
- 1995-03-10 EP EP95103493A patent/EP0671168B1/de not_active Revoked
- 1995-03-10 PT PT95103493T patent/PT671168E/pt unknown
- 1995-03-10 DE DE69517218T patent/DE69517218T2/de not_active Revoked
- 1995-03-10 ES ES95103493T patent/ES2148365T3/es not_active Expired - Lifetime
- 1995-03-10 AT AT95103493T patent/ATE193439T1/de not_active IP Right Cessation
- 1995-03-10 KR KR1019950005014A patent/KR100305234B1/ko not_active IP Right Cessation
- 1995-03-11 CN CN95102282A patent/CN1116523A/zh active Pending
-
2000
- 2000-06-01 GR GR20000401161T patent/GR3033593T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69517218D1 (de) | 2000-07-06 |
CA2144094C (en) | 2004-01-27 |
US5725880A (en) | 1998-03-10 |
GR3033593T3 (en) | 2000-09-29 |
KR100305234B1 (ko) | 2002-04-24 |
DK0671168T3 (da) | 2000-08-07 |
ES2148365T3 (es) | 2000-10-16 |
CN1116523A (zh) | 1996-02-14 |
DE69517218T2 (de) | 2000-11-30 |
CA2144094A1 (en) | 1995-09-12 |
JPH07247222A (ja) | 1995-09-26 |
EP0671168A1 (de) | 1995-09-13 |
JP2917799B2 (ja) | 1999-07-12 |
ATE193439T1 (de) | 2000-06-15 |
KR950031046A (ko) | 1995-12-18 |
TW422708B (en) | 2001-02-21 |
EP0671168B1 (de) | 2000-05-31 |
PT671168E (pt) | 2000-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3033593T3 (en) | Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract. | |
MX9500885A (es) | Preparacion farmaceutica para administracion oral. | |
ATE205705T1 (de) | Arzneimittel zum wirkstoff - targetting in den dickdarm | |
WO1998056360A3 (en) | Film-coated tablet for improved upper gastrointestinal tract safety | |
HU9302379D0 (en) | Peroral medical preparatives with retarded releasing of active agents for treating intestinal diseases | |
ES2149250T3 (es) | Dispositivo para la administracion de medicamentos con liberacion controlada. | |
IL140020A0 (en) | Methods and devices for providing prolonged drug therapy | |
WO2007079082A3 (en) | Gastric release pulse system for drug delivery | |
NO20003640L (no) | Ny doseringsform | |
NZ237516A (en) | Device for drug delivery to intestinal tract comprising a core of active ingredient together with osmotically activated expulsion agent and an outer coating containing a hydrophobic material to assist in delaying release | |
NO940376L (no) | Doseringsanordning for avgivelse av medikament over et tidsrom med kort varighet | |
CA2190148A1 (en) | Oral liquid alendronate formulations | |
SG80553A1 (en) | Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract | |
RU2227033C2 (ru) | Тауролидин и/или таурултам при лечении инфекционной язвенной болезни или инфекционного гастрита | |
WO1998026767A3 (en) | Site-specific controlled release dosage formulation for mesalamine | |
CA2032475A1 (en) | Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines | |
EP0271151A3 (de) | Azumolen-Dosisformen | |
JP2001514218A5 (de) | ||
RU2001131112A (ru) | Препаративная форма для введения в подвздошную кишку, включающая соединение, ингибирующее транспорт подвздошнокишечной желчной кислоты |